|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
16
|
|
pubmed:dateCreated |
1999-11-23
|
|
pubmed:abstractText |
This study represents the Heart Center Rotterdam's contribution to the Isostents for Restenosis Intervention Study, a nonrandomized multicenter trial evaluating the safety and feasibility of the radioactive Isostent in patients with single coronary artery disease. Restenosis after stent implantation is primarily caused by neointimal hyperplasia. In animal studies, beta-particle-emitting radioactive stents decrease neointimal hyperplasia by inhibiting smooth muscle cell proliferation.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Oct
|
|
pubmed:issn |
1524-4539
|
|
pubmed:author |
|
|
pubmed:issnType |
Electronic
|
|
pubmed:day |
19
|
|
pubmed:volume |
100
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1684-9
|
|
pubmed:dateRevised |
2009-11-19
|
|
pubmed:meshHeading |
pubmed-meshheading:10525486-Adult,
pubmed-meshheading:10525486-Aged,
pubmed-meshheading:10525486-Aspirin,
pubmed-meshheading:10525486-Beta Particles,
pubmed-meshheading:10525486-Brachytherapy,
pubmed-meshheading:10525486-Coronary Angiography,
pubmed-meshheading:10525486-Coronary Disease,
pubmed-meshheading:10525486-Feasibility Studies,
pubmed-meshheading:10525486-Female,
pubmed-meshheading:10525486-Follow-Up Studies,
pubmed-meshheading:10525486-Graft Occlusion, Vascular,
pubmed-meshheading:10525486-Humans,
pubmed-meshheading:10525486-Male,
pubmed-meshheading:10525486-Middle Aged,
pubmed-meshheading:10525486-Patient Selection,
pubmed-meshheading:10525486-Phosphorus Radioisotopes,
pubmed-meshheading:10525486-Platelet Aggregation Inhibitors,
pubmed-meshheading:10525486-Stents,
pubmed-meshheading:10525486-Ticlopidine
|
|
pubmed:year |
1999
|
|
pubmed:articleTitle |
beta-Particle-emitting radioactive stent implantation. A safety and feasibility study.
|
|
pubmed:affiliation |
Thoraxcenter, Heartcenter, University Hospital Rotterdam, Dijkzigt The Netherlands. Rotterdam, The Netherlands.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Research Support, Non-U.S. Gov't,
Multicenter Study
|
